Methylphenidate HCL IR
Awarded Award Notice Posted
- Solicitation number
- SPE2D224D0008
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Awarded
- to Specgx LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2D224D0008 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Hobart, New York 13788, United States
- Points of contact
-
- Jason Wray jason.wray@dla.mil (445) 737-6304
- Nancy Fernandez nancy.fernandez@dla.mil (215) 737-4955
- Lisa Quinn lisa.quinn@dla.mil (215) 737-8787
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical awarded contract SPE2D224D0008 to SpecGx, LLC for $5.892 million over a 5-year base period with 5 option years for Methylphenidate HCL immediate-release tablets (5 mg, 10 mg, and 20 mg formulations in 100-count unit packs), with the initial award made on September 27, 2024.
Place of performance is Hobart, NY. The award was made under no set-aside. Option Year One was exercised September 27, 2025, with unit price reductions: CLIN 0001 (5 mg) to $9.65 per unit, CLIN 0002 (10 mg) to $13.65 per unit, and CLIN 0003 (20 mg) to $18.04 per unit. Option Year Two was exercised September 27, 2026, extending performance through September 26, 2027. The contract incorporates FAR and DFARS clauses including small business subcontracting and Pharmaceutical Prime Vendor requirements. A May 2025 modification implemented Class Deviations 2025-O0003 and 2025-O0004, narrowing sustainability and compliance clause applicability.
Notice text
2 versions
Update #2 · Latest ·
MOD for Option Year Two (2) is attached.
Awarded contract SPE2D224D0008 to SpecGx, LLC for 5892883.55 on 2024-09-27.
Update #1 ·
Methylphenidate Award
Awarded contract SPE2D224D0008 to SpecGx, LLC for 5892883.55 on 2024-09-27.
Attachments
| File | Type | Posted |
|---|---|---|
| SF30_SPE2D224D0008P00004.PDF | ||
| MOD P0002 - Price Decrease and Exercising Option Year - Methylphenidate HCL IR 2.pdf | ||
| SF30_SPE2D224D0008P00001.PDF.pdf | ||
| Signed Award - Methylphenidate SPE2D2-24-D-0008.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Methylphenidate HCL IR | Award Notice | |
| Methylphenidate HCL IR | Solicitation | |
| Methylphenidate HCL IR | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity